Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2Article Published on 2022-02-172022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] anti-spike IgG levels AZD1222 BNT162b2 breakthrough infections Capacity Cellular immune response clinically evaluated comparable COVID-19 Delta delta variant Efficacy group Health care worker heterologous prime-boost Heterologous prime-boost vaccination highest homologous humoral humoral and cellular immune response IFNγ Level magnitude Month neutralizing capacity offered peptide peptides question Receptor binding domain recruited regimen resulting SARS-CoV-2 SARS-CoV-2 vaccine secretion significantly significantly higher spike symptomatic disease the vaccine vaccination Vaccinations Vaccine variant of concern variants of concern viral neutralization wild type Wuhan-Hu-1 [DOI] 10.3390/vaccines10020322 PMC 바로가기 [Article Type] Article
Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine천연 SARS-CoV-2 감염 또는 COVID-19 백신에 의해 소아에서 유도된 중화 항체에 대한 오미크론 변이체 감수성Coronaviruses Published on 2022-02-102022-09-10 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] adult COVID-19 patient adult COVID-19 patients Affect age Antibody Response Antibody titer Beta Beta variant BNT162b2 breakthrough infections children collected conducted COVID-19 patient COVID-19 patients COVID-19 vaccine Critical demonstrated individual Live virus microneutralization MOST Mutation neutralization neutralizing antibody Neutralizing antibody response Neutralizing antibody titer of BNT162b2 omicron Omicron variant pediatric Pfizer-BioNTech Re-infection recipient recipients recovered COVID-19 patient Recovered COVID-19 patients Reinfection risk SARS-CoV-2 SARS-COV-2 infection serum Serum Neutralization specimen specimens Spike protein susceptibility susceptible the spike protein threshold titre Vaccine vaccine breakthrough infection vaccine breakthrough infections variant variant of concern variants virus [DOI] 10.1080/22221751.2022.2035195 PMC 바로가기 [Article Type] Coronaviruses
Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination ProgramsViewpoint Published on 2022-02-072022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] absence approval booster Breakthrough infection breakthrough infections COVID-19 global public health globe infecting pandemic Program public health public health communication remained SARS-CoV-2 SARS-CoV-2 infections SARS-CoV-2 vaccine significantly Spread Unpacking vaccination Vaccine Vaccine hesitancy Vaccine-induced immunity variants of interest waning immunity [DOI] 10.3390/vaccines10020252 PMC 바로가기 [Article Type] Viewpoint
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy새로운 바이러스 변종, 획기적인 감염 및 백신 주저에 직면하여 Covid-19 완화Review Published on 2022-02-012022-09-11 Journal: Journal of autoimmunity [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] Antibody Response approach B cell B cell memory being booster Breakthrough infection breakthrough infections Cell condition conserved COVID-19 virus creating Critical death Delta disease effective evade facilitate follicular Germinal center Global vaccination helper cells Hospitalization Immunity immunization Interaction multivalent vaccine mutate Mutation notable omicron Omicron variant Omicron variants pandemic Perspective Proteins public health emergency resulting RNA RNA virus robust SARS-CoV-2 Second-generation vaccines Spread T follicular helper cells the antibody response translational Transmissibility Transparency vaccination Vaccine Vaccine hesitancy Vaccines variant variants variants of SARS-CoV-2 Viral viral mutation Viral mutations Viral protein Viral proteins virus virus variants [DOI] 10.1016/j.jaut.2021.102792 PMC 바로가기 [Article Type] Review
Actions and attitudes on the immunized patients against SARS-CoV-2SARS-CoV-2에 대한 면역 환자의 행동과 태도Review Published on 2022-02-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 변종, [키워드] Action age Asymptomatic Breakthrough infection breakthrough infections Care circulating variants college Committee Consensus consequence Contact contact with country COVID COVID-19 decrease diagnostic test diagnostic tests English exploratory Follow-up follow-up of immunized persons forms General population Health care Health care worker health care workers Hospitalization immune response immunized infected patient Infection information Mask Masks mass vaccination Mild natural infection new SARS-CoV-2 observation occur Occurrence Patient patients physician Precision proportion quarantine question Reinfection revaccination SARS-CoV-2 SARS-CoV-2 infections screening test social distancing Society Spanish subject suggested the disease Transmission use of masks vaccination Vaccine vaccine escape variable Viral variants [DOI] 10.37201/req/131.2021 PMC 바로가기 [Article Type] Review
Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants델타 및 알파 변이체에 감염된 백신 접종자의 돌발 감염 예방에 대한 코로나바이러스 백신의 비교 효과Research Published on 2022-02-012022-09-10 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 변종, [키워드] acute respiratory syndrome adjusted age Alpha Alpha variant Breakthrough infection breakthrough infections Comparative coronavirus coronavirus disease coronavirus variants COVID-19 Cycle threshold value Delta delta variant Diagnosis Effectiveness Infection Logistic regression mean difference mRNA vaccine mRNA vaccines Odds ratio Patient PCR cycle PCR-positive Person Portugal Preventing preventing infection reported respiratory respiratory infections SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 Sex significantly higher threshold value used data vaccination Vaccination Status Vaccine vaccine-preventable diseases variant Viral Viral load viruses zoonoses [DOI] 10.3201/eid2802.211789 PMC 바로가기 [Article Type] Research
Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study프랑스 성인의 COVID-19 입원에 대한 백신 효과: 테스트 음성 사례 대조군 연구Article Published on 2022-02-012022-09-11 Journal: Infectious diseases now [Category] COVID19(2023년), SARS, 변종, [키워드] Alpha Alpha variant breakthrough infections case control study controls COVID-19 COVID-19 hospitalization COVID-19 vaccine Critical dose doses Effectiveness FIVE France hospital Hospitalization hospitalizations Immunocompromised patients negative test Patient patients hospitalized Prevent Symptom test negative vaccination Vaccine vaccine effectiveness variant with COVID-19 [DOI] 10.1016/j.idnow.2021.12.002 PMC 바로가기 [Article Type] Article
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infectionsArticle Published on 2022-01-272022-10-29 Journal: Nature Communications [Category] COVID-19, [키워드] acquisition Analysis benefit BNT162b2 Breakthrough infection breakthrough infections Cohort correlated COVID-19 vaccine cycle threshold diagnosed Epidemiology Health individuals Infection infections less Moderna mRNA-1273 National Pfizer-BioNTech Primary infection PROTECT Public public health Randomly Reinfection relative RT-qPCR SARS-CoV-2 SARS-CoV-2 vaccine Transmission transmission potential vaccinated individual vaccination vaccine breakthrough infection viral infection Viral load virus [DOI] 10.1038/s41467-022-28199-7 PMC 바로가기 [Article Type] Article
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections백신 접종 후 SARS-CoV-2 델타 변이체 감염으로 인한 바이러스 배출 및 배양 양성 기간Research Article Published on 2022-01-252022-09-10 Journal: JCI Insight [Category] 변종, 치료기술, [키워드] 24 hour 24 hours acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 ambulatory patient ambulatory patients Asymptomatic Breakthrough infection breakthrough infections characterized Cohort collected coronavirus correlated COVID-19 Culture delta variant Duration early stage early stages Epidemiology evaluate greater individual Infection infections Infectious disease initial viral load Isolation likelihood nasal swab nasal swabs PCR PCR positivity postvaccination quantification Replication replication-competent virus resolution of symptoms respiratory SARS-CoV-2 SARS-CoV-2 delta SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 viral load severe acute respiratory syndrome Coronavirus Support symptom onset symptom resolution symptomatic symptomatic individual symptomatic individuals These data US CDC vaccination variant variants Viral viral culture viral load quantification viral shedding virus whole-genome sequencing [DOI] 10.1172/jci.insight.155483 PMC 바로가기 [Article Type] Research Article
An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward정신과 폐쇄 병동에서 SARS-CoV-2 델타 변종에 의한 획기적인 감염 발생Article Published on 2022-01-242022-09-11 Journal: Journal of Korean medical science [Category] 변종, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 breakthrough Breakthrough infection breakthrough infections caused ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine Clinical data coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis COVID-19 outbreak Delta delta variant demographic dose duration of hospitalization Epidemic highlight hospital Hospitalization Immunity index case infecting information less Neutralizing activity occurred outbreak Patient PCR test prevalent Prevent Prolonged Psychiatric Psychiatric Hospital reduce mortality reported SARS-CoV-2 SARS-CoV-2 Delta variant SARS-CoV-2 PCR test SARS-CoV-2 PCR test results second vaccination severe acute respiratory syndrome Coronavirus Spread the SARS-CoV-2 vaccination Vaccine vaccinee vaccinees variant ward [DOI] 10.3346/jkms.2022.37.e28 PMC 바로가기 [Article Type] Article